Posts by April M. Jorge, MD
-
COVID-19 Patients with Rheumatic and Musculoskeletal Diseases at Substantial Risk of Poor Outcomes
Clinicians in the Division of Rheumatology, Allergy and Immunology found that for patients with rheumatic and musculoskeletal diseases who develop COVID-19, the risks of death and other severe outcomes have declined since early in the pandemic but remain considerable.
Biography
April Jorge, MD is a graduate of Georgetown University School of Medicine. She completed her Internal Medicine residency at Northwestern University, and she completed her Rheumatology training at Massachusetts General Hospital. Following her Rheumatology fellowship, she joined the Rheumatology Unit within the Division of Rheumatology, Allergy, and Immunology in the Department of Medicine. In addition to seeing patients in the Rheumatology Clinic, Dr. Jorge receives grant funding to conduct clinical epidemiology research in systemic lupus erythematosus (lupus) and related diseases. She is a member of the Clinical Epidemiology Program of the Division of Rheumatology, Allergy, and Immunology. She also serves as a site investigator and enrolls patients in clinical trials of potential new lupus treatments. Her clinical interests include lupus, other related autoimmune disorders, and women's health issues for patients with rheumatic diseases.
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.